Mesenchymal stem cell (MSC) transplantation is a promising therapy for acute kidney injury; however, the efficacy is limited due to poor survival after transplantation. In this study, we investigated how MSC transplantation timing affected the survival and therapeutic potential of MSCs in the kidney ischemia-reperfusion (I/R) injury model. After kidney I/R injury, the inflammatory process and tissue damage were characterized over 1 week post
Introduction
Acute kidney injury (AKI) is characterized by an abrupt decline of renal function experienced by as many as 2%-4% of hospitalized patients [1] [2] [3] [4] [5] . AKI most commonly occurs after ischemia or nephrotoxic insult and carries a high risk of mortality [6, 7] . Dialysis, the most common treatment for AKI, has been steadily improving; however, innovative interventions are needed to improve patients' outcomes [4, 6] . Additionally, despite return of renal function, permanent pathological kidney damage may remain. Incomplete repair of this damage can result in tubule interstitial fibrosis that can progress into chronic kidney disease [8, 9] . Therefore, new treatments are urgently needed to inhibit renal cell apoptosis and expedite the recovery from AKI.
Growing evidence suggests that bone mesenchymal stem cells (MSCs) could be a promising therapeutic application for AKI because they carry no immunogenicity, thus do not require immunosuppression, and the cells are able to migrate to injury sites to ameliorate structural and functional damage of kidney injury organs via multiple mechanisms, including regulation of the immune system [10] [11] [12] [13] [14] . Furthermore, MSCs have passed Phase II clinical trials [15] . However, decreased migration to injured renal tissue and reduced survival in the microenvironment limited the effectiveness of MSCs in treating AKI [16] [17] [18] . To increase the therapeutic effect of MSCs for AKI, it is imperative to improve their homing to the kidney and survival within the injured organ [18] .
A potential reason for decreased homing and survival of MSCs is the inflammatory environment generated within the target sites [19, 20] . In AKI, inflammation is differentially expressed over time [21] . We speculate that the changing of inflammatory environment may affect MSCs, and the timing of MSC administration may be crucial to overcome the inhibitory effects of the inflammation response. Previous studies on acute myocardial infarction and cerebral infarction have demonstrated that the timing of MSC administration relative to the injury significantly impacts MSC efficacy, supporting our hypothesis [20, [22] [23] [24] [25] .
As a method to treat AKI, the optimal timing of MSC treatment is an issue to be solved in clinic. However, the timing is not unified at present. This disunity may be part of the reason why the therapeutic effects of different researches are inconsistent. With these issues, in this study, the inflammation in injured kidneys during the time course of ischemia-reperfusion (I/R) injury and the effect of different timings of MSC administration on the therapeutic potential were assessed in the I/R model of AKI in rats.
Materials and Methods

Animals
Experimental male Sprague-Dawley rats (weighing 250-300 g) and MSC donor rats (weighing 50-100 g) were obtained from the Animal Center, Shanghai Medical College, Fudan University (Shanghai, China). All procedures were approved by the Institutional Animal Care Use Committee of Fudan University.
I/R kidney injury
Rats were anesthetized with an intraperitoneal injection of 40 mg/kg pentobarbital sodium. Warm kidney I/R model was induced by bilateral kidney pedicle clamping for 60 min, followed by reperfusion. Sham controls underwent all the same surgical procedures except vascular occlusion.
Histological analysis
Formalin-fixed and paraffin-embedded kidney samples were cut in 3-µm sections and stained with hematoxylin and eosin (HE). At ×200 magnification, 10 non-overlapping fields along the boundary between kidney cortex and medulla were randomly selected and injury severity was scored according to the percentage of damaged tubules (tubular cell necrosis, loss of brush border, tubular dilation, and/or luminal cast formation) in a blinded manner: 0 (normal), 0%-9%; 1, 10%-25%; 2, 26%-50%; 3, 51%-75%; and 4, ≥ 76% [26] .
Immunohistochemistry (IHC) was performed as described previously [27] , with anti-ED-1 antibody (1:100; Chemicon, Temecula, USA) for the detection of infiltrating macrophages/monocytes and anti-Ki-67 antibody (1:100; Abcam, Cambridge, UK) for labeling proliferating tubular epithelial cells. Tissue was then incubated with horseradish peroxidase-conjugated secondary antibody (anti-rabbit IgG), then stained with 3,3′-diaminobenzidine (Sigma, Shanghai, China) and counterstained with HE. Cells positive for ED-1 or Ki-67 were counted in 10 random fields at the kidney corticomedullary border at ×200 magnification by a pathologist in a blinded manner.
Reverse transcriptase-polymerase chain reaction
Total ribonucleicacid was extracted from kidney homogenates using Trizol reagent (Invitrogen, Carlsbad, USA) and then reverse transcribed to complementary DNA using a reverse transcription polymerase chain reaction (PCR) kit (Takara, Tokyo, Japan). Reverse transcriptase-PCR (RT-PCR) was performed using SYBR ® Premix
Ex Taq II (Takara) on the Applied Biosystems System (ABI7500; ABI, Foster City, USA) with primers listed in Table 1 . β-Actin served as a housekeeping gene. Relative gene expression was calculated using the ΔCt method.
Enzyme-linked immunosorbent assay
Dissected kidney tissue was flash frozen in liquid nitrogen, homogenized, and levels of TNF-α, IL-1β, IL-10, intercellular cell adhesion molecule (ICAM-1) and vascular cell adhesion molecule (VCAM-1) were measured in triplicate with corresponding enzyme-linked immunosorbent assay (ELISA) kits following manufacturer's instructions, using anti-ICAM-1 antibody (R&D, Minneapolis, USA) and anti-VCAM-1 antibody (Uscn LifeScience, Wuhan, China).
Creatinine and neutrophil gelatinase-associated lipocalin measurements
After anesthesia, blood was collected from abdominal aorta and urine was collected by bladder puncture. Serum creatinine (Scr) was measured by a Hitachi7180 automatic analyzer (Hitachi, Tokyo, Japan). An ELISA kit for urine neutrophil gelatinase-associated lipocalin (NGAL) (Abcam) was used for quantification. 
MSC harvest and transplantation
MSCs were collected from rats using previously published procedures [28] . Briefly, bone marrow was flushed from rat femurs and tibias with dulbecco's modified Eagle's medium (DMEM) (Invitrogen) and cultured. After four passages, MSCs displayed a uniform fibroblast-like appearance. The MSC phenotype (CD29+, CD90+, and CD45−) was confirmed by flow cytometry. In general, cultures were 99% CD29+, 99% CD90+, and 0.042% CD45+ ( Supplementary Fig. S1 ). Each batch of MSCs was further characterized by observing osteogenic and adipogenic differentiation ( Supplementary Fig. S2 ). Cells from passage 6 to 8 were used for transplantation. Prior to injection, cultures with ≥80% confluence were detached, and labeled with CM-DiI (Invitrogen) according to manufacturer's instructions. The labeling efficiency was >98% ( Supplementary Fig. S3 ). Trypan blue staining showed that CM-DiI labeling had no adverse effect on cell viability compared with non-labeled MSCs ( Supplementary Fig. S4 ). Totally, 1×10
6 CM-DiI labeled MSCs in phosphate buffered saline (PBS) were injected into the left carotid artery. The animals in the control group underwent the same surgical intervention and received an equal volume of cell-free PBS (vehicle).
Preparation of I/R kidney homogenate supernatant
Immediately after harvest, kidneys were cut into pieces, weighed, and then homogenized at 50 mg/ml in DEME using automatic sample grinding mills at 4°C. The homogenate was centrifuged at 3000 g for 10 min at 4°C, and the supernatant was filtered through 0.22-μm filtration membrane and reserved for experimentation.
Measurement of cell apoptosis
Annexin V Apoptosis Detection Kit (eBioscience, San Diego, USA) was used to detect cell apoptosis. After MSCs reached 80% confluence in a six-well plate, medium was replaced with 2 ml fresh cell culture medium (control) or 2 ml kidney homogenate supernatant. MSC apoptosis was determined after 24 h by flow cytometry.
Measurement of cell viability
Cells were seeded into a 96-well plate (5×10 3 cells per well). After incubation for 24 h, medium was removed and 100 μl cell culture medium (control) or 100 μl kidney homogenate supernatant was added. After another 10 h, alamarBlue ® reagent (Invitrogen) was added and incubated for an additional 4 h. Cell viability was measured per manufacturer's instructions.
Transwell migration assay
MSCs (1×10 6 cells/ml) were resuspended in serum-free DMEM and 200 μl was added to the upper chamber of an 8-μm pore transwell system (Costar, Cambridge, USA). In the lower chamber, 2 ml of kidney homogenate supernatant or cell medium only (control) was added. After 12 h, the membrane was fixed with 4% paraformaldehyde. Cells on the upper side of the membrane were removed with a cotton swab and cells migrated to the lower surface were stained with crystal violet. Cells in five random non-overlapping fields were counted at ×200 magnification.
Assessment of MSC transplantation
To quantify renal tubular cell apoptosis, frozen sections at 5-µm thickness underwent a TUNEL reaction, followed by processing with an In Situ Cell Death Detection Kit (Roche, Basel, Switzerland) per manufacturer's instructions. TUNEL-positive cells at the renal corticomedullary boundary zone were counted at ×200 magnification using a Leica TCS SP5 fluorescent confocal microscope (Leica, Wetzlar, Germany).
To measure the survival of grafted MSCs in the kidney, frozen sections were stained with DAPI and observed at ×200 and ×630 magnification using the fluorescent confocal microscope. MSCs colabeled with CM-DiI and DAPI nuclear staining were counted in 10 non-sequential sections under ×200 magnification.
Statistical analysis
Statistical analyses were performed using GraphPad Prism software and the results were presented as the mean ± SD. For comparison with more than two subgroups, the nonparametric Kruskal-Wallis ANOVA followed by Dunnett was performed. P < 0.05 indicated statistically significant difference.
Results
Physiological and inflammatory changes in the I/R injured kidney HE staining of kidney tissue at various time points (1 h, 12 h, 24 h, 48 h, 72 h, and 1 week) post-I/R injury revealed that significant pathology developed at 12 h post-I/R (h.p.i.), peaked at 24-48 h.p.i., then began to reverse at 72 h.p.i. (Fig. 1A,B) . Pathologies observed at the corticomedullary boundary zone included tubular cells detachment, luminal cast formation, and lymphocyte infiltration.
ED-1 IHC was performed to identify infiltrating macrophages and monocytes. ED-1+ cells began significantly accumulating at 12 h.p.i., and peaked at 12-72 h.p.i. (Fig. 1C,D) , then declined at 1 week post injury, indicating an attenuation of the innate immune reaction that corresponds with decreased renal pathology.
Molecular characterization of the immune response was performed by examining mRNA and protein expression of two proinflammatory cytokines (TNF-α and IL-1β), an anti-inflammatory cytokine (IL-10), and two adherence factors (ICAM-1 and VCAM-1). For all genes examined, expression peaked at 12 h.p.i. (P < 0.05), then tapered off for the remainder of the time course (Fig. 1E ). Protein expression levels followed a similar pattern, with a peak at 12 h.p.i. (P < 0.05), and IL-10 levels also remained elevated at 24 h. p.i. as well (Fig. 1F) .
Biomarkers after I/R injury
Scr was significantly increased at 1 h.p.i. compared to sham-operated animals, and peaked at 24 h.p.i. (Fig. 2A) . Urine NGAL was also increased at 1 h.p.i., and peaked earlier than Scr at 12 h.p.i. (Fig. 2B) .
For the purposes of this study, we wanted to test the use of urine NGAL as a noninvasive biomarker that could correlate with the inflammatory reaction in the injured kidney. To verify its feasibility for this purpose, correlation coefficients were calculated between NGAL and inflammatory cytokine expression throughout the time course. Urine NGAL was positively correlated with TNF-α (r = 0.9518, P = 0.001), IL-1β (r = 0.9669, P = 0.0004), and IL-10 (r = 0.9253, P = 0.0028) protein expression in the kidney (Fig. 2C) .
All of the data collected thus far were graphed together to depict the trends in protein and biomarker expression after I/R injury (Fig. 3) . Overall, these data demonstrate that cytokine expression is 
Effects of I/R microenvironment on MSC survival and function in vitro
To evaluate the influence of the inflammatory post-I/R renal microenvironment on MSCs, in vitro assessments of apoptosis, viability, and migration capabilities of MSCs were performed. The microenvironment was mimicked by culturing MSCs in supernatants derived from I/R kidney homogenates collected at various time points post-injury, ranging from 1 h to 1 week.
Compared with cells cultured in normal cell culture medium, MSCs exposed to kidney homogenate supernatant had significantly higher apoptosis measured by annexin V uptake (Fig. 4A) . Of the experimental time points (1 h, 12 h, 24 h, 48 h, 72 h, and 1 week) post-I/R, the 1 h, 72 h, and 1 week post-I/R supernatants induced the least amount of apoptosis, whereas 12 h was the most cytotoxic (Fig. 4C) .
To assess the migratory behavior of MSCs, transwell migration assays were performed, and results showed that the number of migrated MSCs was significantly greater in 1, 12, 24, and 48 h groups than those in the sham, 72 h, 1 week, and normal cell medium groups (Fig. 4B,D) . Moreover, the highest number of migrated MSCs was observed in 1 and 12 h groups.
Further characterization of MSC viability was performed using alamarBlue. The cell viability trend paralleled the annexin V apoptosis results, where 12 and 24 h supernatant had the most deleterious effect on cell viability (P < 0.05). Cell viability was decreased in the presence of sham, as well as the 1 h, 48 h, 72 h, and 1 week supernatants, but not to the extent of 12 and 24 h supernatants (Fig. 4E) .
MSC survival following various administration times post-I/R injury
The above results indicated that a robust inflammatory reaction occurred at 12-48 h post-I/R injury, then resolved between 72 h and 1 week. To employ MSCs therapeutically for AKI, we hypothesized that the ideal administration time would be either 0 (immediately after ischemia), 1, 12, or 24 h post-I/R. In the preliminary experiments, there were no significant changes in pathological damage and Scr levels when treated with PBS at different time points. Therefore, treatment with PBS at 1 h post-I/R was selected in the experiment.
Prior to transplantation, MSCs were labeled with CM-DiI for histological detection. To determine the effect of different environment on MSC survival, kidney tissue sections of 12 h after MSC injection were assessed. In this study, maximum MSC grafting was observed when cells were administered immediately after ischemia or 1 h post-injury, with~18 or 19 MSCs visible per field (Fig. 5A) . MSC administration at 12 and 24 h.p.i. resulted in an approximate 50% reduction in MSC presence in the kidney (Fig. 5B) .
Therapeutic potential of MSCs affected by administration timing
To measure if there was a therapeutic effect of MSC treatment, Scr, HE pathology, renal epithelial cell division, and apoptosis were all measured at 48 h.p.i.
It was shown that immediate, 1, and 24 h MSC treatments resulted in a significant decrease in Scr level compared with PBS control, whereas 12 h MSC administration did not (Fig. 6A) . In PBStreated animals, the HE injury score was almost maximal (4 ± 0.34), and immediate and 1 h MSC treatments were decreased by~1 point (actual number here), indicating mirroring the Scr effect (Fig. 6B,C) . MSC treatments for 12 and 24 h were not significantly different from PBS.
To determine the proliferation of tubular epithelial cells, Ki-67 staining was performed. There was a marked increase in Ki-67+ cells in MSC-treated groups than PBS control (Fig. 6D ,E, P < 0.05). Ki-67+ cells were most prevalent in immediate and 1 h treatment groups, and significantly lower in 12 and 24 h treatment groups. TUNEL analysis was performed to identify apoptotic tubular cells. Apoptotic cells were significantly decreased in all treated groups compared with PBS control (Fig. 6F,G) . Apoptosis was lower in immediate and 1 h treatment groups, and higher in 12 and 24 h treatment groups, further paralleling the above findings.
MSC modulation of the I/R inflammatory response is affected by administration timing MSC treatment significantly reduced monocyte/macrophage infiltration in the injured kidney compared to the control group (Fig. 7A,B) . The greatest reductions were observed in immediate and 1 h treatments, and the 12 and 24 h treatments were less effective in reducing myeloid cell infiltration.
ELISA and RT-PCR assays revealed that in MSC treatment groups, TNF-α and IL-1β were markedly decreased, and IL-10 was increased, compared with the control groups (Fig. 7C,D , P < 0.05). Furthermore, immediate and 1 h MSC treatment groups exhibited lower mRNA and protein levels of TNF-α and IL-1β, but higher IL-10 level relative to 12 and 24 h treatment groups.
Discussion
The present study demonstrated that cellular and molecular markers for inflammation were different during the time course of renal I/R injury. Also, the negative effects of renal inflammation on the survival and function of MSCs were determined in our study. The optimal timing for transplantation is immediately after ischemia to 1 h after perfusion when severe inflammatory response does not occur.
Inflammation is the main physiopathology of ischemia/hypoxia [29] . Characteristic of I/R renal injury is the prominent infiltration of leukocytes. Macrophage infiltration plays a key role in the initiation and orchestration of acute inflammatory responses in renal injury [30] . We tested macrophage infiltration and inflammatory cytokines in the injured kidneys and found that there were different inflammatory levels at different time points post-I/R, which was consistent with the results in acute myocardial infarction animal model [20, 31] . Recent studies show that the inflammatory status described above greatly affects the efficiency of MSCs [17, 32, 33] . In this study, we demonstrated that the therapeutic efficacy of MSCs in renal I/R injury was time dependent.
The timing of MSC administration has been studied in some ischemic disease models [20, 22, 24, 25, 29, 34] , however in AKI, there is a dearth of research. Lange et al. [35] reported that transplantation of MSCs either immediately or 24 h post-I/R resulted in significant renoprotection; however, there was no further comparison of different time points. Another study of MSC treatment for renal I/R was performed in sheep, and it showed that immediate MSC treatment was superior to 15 days post-I/R, but no more time points were examined [36] . A recent meta-analysis of MSC administration in kidney disease revealed that cell administration >1 day after injury yielded greater therapeutic value than within 24 h of injury. However, the meta-analysis included multiple types of injury, including acute, chronic, and toxic renal injuries, which made the results of the meta-analysis difficult to interpret [37] . Therefore, direct comparisons by a standardized approach are imperative.
Overall, we propose that the timing of MSC administration should be immediately after ischemia to 1 h post-I/R, due to three beneficial processes. First, the lack of inflammation in the early injured kidney was favorable for MSC survival within the tissue, thus increasing the dose of the stem cell effect. Second, as shown in the molecular data, favorable expression of homing adhesion molecules ICAM-1 and VCAM-1 were present, further promoting MSCs to integrate into injured kidney tissue [38, 39] . Third, pro-inflammatory markers TNF-α and IL-1β were down-regulated in the I/R kidney tissue after MSC transplantation. The early presence of MSCs attenuates the inflammatory cascade and prevents development of severe tissue damage, which is consistent with previous evidence describing the anti-inflammatory effects of MSCs [8, 16, 28, 35] .
It should be emphasized that in our study 48 h post-I/R was selected as the observation destination for the consideration that there were enough time to work whether MSCs were infused 0 h, 1 h, 12 h, or 24 h post-I/R, because infused MSCs quickly attached in the kidney within 10 min of intra-arterial injection and most of them were cleared within 24 h [16] . In addition, the reparative effects of MSCs can be primarily ascribed to their endocrine/paracrine of cytokines [40] , which are known of short half-life [41, 42] .
The changing inflammatory environment affects therapeutic potential of MSCs. Therefore, it is desirable to get some noninvasive clinical examinations that could reflect the renal inflammatory status instead of invasive renal biopsy. NGAL, richly expressed in inflammatory cells [43] , has been correlated with inflammation in multiple other diseases [44] [45] [46] [47] [48] [49] ; however, its relevance with inflammation in AKI has not been studied. Our data suggest that NGAL may be helpful to assess renal inflammation in AKI rats, but more explorations are still needed.
Therefore, in clinical application, MSCs should be injected as early as the renal ischemic occurs. Hierarchical evaluation of AKI risk is needed for high-risk patients such as patients with heart transplantation, renal transplantation, or other major operations. It is suggested that MSC treatment should be applied intraoperatively. In a clinical study, this time-point was also selected to inject MSCs immediately when extracorporeal circulation was established, in other words, immediately after renal ischemic [14] . Our study further provides theoretical basis for the above time-point. In addition, except for some major operations such as heart operation, the exact time of renal ischemic (such as ICU patients) cannot be determined in many AKI patients. As to these high-risk AKI patients, the urine NGAL, and Scr should be monitored rigorously. According to our result, MSCs may be injected when urine NGAL (F,G) Quantification and images (magnification, ×200) of tubular cell apoptosis at the renal corticomedullary boundary zone using the TUNEL apoptosis stain (green) and DAPI nuclear stain (blue). Data are presented as the mean ± SD. *P < 0.05 versus PBS group; # P < 0.05 versus group 1hM. MSC, mesenchymal stem cell; IHC, immunohistochemistry; PBS, phosphate buffered saline; I/R, ischemia-reperfusion; HE, hematoxylin and eosin; Scr, serum creatinine.
begins to increase without significant changes in Scr level, at which time the inflammation in kidney is relatively low. In summary, our findings suggest that by closely monitoring urine NGAL, the development of kidney inflammation can be detected, and rapid administration of MSCs can be performed when they have maximum therapeutic value.
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